Minerva Neurosciences, Inc. Gains 69.27%
Wed, Jun 28, 2023 at 07:40 PM
Minerva Neurosciences, Inc. (NERV:NASDAQ) shot up at $10.19, representing a gain of 69.3%. On Wed, Jun 28, 2023, NERV:NASDAQ hit a New 2-Week High of $10.19. The stock got featured on our News Catalysts scanner on Wed, Jun 28, 2023 at 11:23 AM in the 'PRIVATE PLACEMENT' category. From Wed, Jun 14, 2023, the stock recorded 11.11% Up Days and 30.00% Green Days
About Minerva Neurosciences, Inc. (NERV:NASDAQ)
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system, or CNS, diseases.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 80%
- Minerva Neurosciences, Inc. (NERV:NASDAQ), 69.27%
- Signature Bank (SBNY:NASDAQ), 61.79%
- Knightscope Inc. (KSCP:NASDAQ), 52.15%
- Joby Aviation Inc. (JOBY:NYSE), 40.22%
- Kaleyra Inc. (KLR:NYSE), 39.38%
- Centogene N.V. (CNTG:NASDAQ), 33.9%
- Evelo Biosciences, Inc. (EVLO:NASDAQ), 33.86%
- Trio Petroleum Corp. (TPET:NYSEMKT), 33.64%
- AgeX Therapeutics, Inc. (AGE:NYSEMKT), 32.27%